Skip to main content
. 2016 Jun;8(6):1250–1256. doi: 10.21037/jtd.2016.04.21

Table 3. Multivariate analysis of survival on clinical and pathologic factors.

Variables Risk ratio (95% CI) P value
Stage Ia 0.14 (0.04–0.50) 0.002*
Stage IIa 0.26 (0.11–0.58) 0.001*
Age 0.852
Sex 0.596
Histology homology 0.382
Lymph node metastasis 0.285
Lymphovascular invasion 0.771
Tumor location 0.805
Adjutant therapy 0.191

a, stage III was set as reference (RR=1.00). *, P<0.05.